The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The efficacy of UDCA in treating the parenteral nutrition-associated cholestasis(PNAC) has
been identified by some studies in children without short bowel syndrome(SBS).Most of the
adults who suffering PNAC have SBS. it limits the potential function of UDCA because of the
lack of SBS patients and malabsorption of UDCA.Therefore, we design this clinical trial in
our center of SBS to approach the preventative and therapeutical effect of UDCA to PNAC in
adults with short bowel syndrome.